NCT03921060View on ClinicalTrials.gov

Markers of Osteoporosis in Cystic Fibrosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 2, 2021

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Cystic Fibrosis
Interventions
DRUG

Denosumab

treatment with denosumab every 6 months for up to 5 years

Trial Locations (1)

75390

RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER